このポッドキャストについて 🔗
A conversation series with leaders in the psychedelic community. Designed in service of therapists, healers, retreat leaders, and passionate enthusiasts.
ホスト:
更新頻度:
every 79 days
平均音声長:
63 minutes
ゲストインタビュー
スポンサーがいる
英語
アメリカ合衆国
71 エピソード
2020年5月1日から
episodic
AUDIENCE OF THIS PODCAST 🔗
~82.65% of listeners are from United States.
🇺🇸
US
82.65%
🇨🇦
CA
4.42%
🇬🇧
GB
3.32%
🇪🇸
ES
2.21%
🇩🇪
DE
1.10%
🇨🇷
CR
1.10%
🇳🇱
NL
1.10%
🇨🇭
CH
0.73%
🇷🇪
RE
0.73%
🇮🇱
IL
0.36%
🇷🇺
RU
0.36%
🇵🇭
PH
0.36%
🇺🇾
UY
0.36%
🇮🇪
IE
0.36%
🇦🇺
AU
0.36%
🇵🇱
PL
0.36%
Others
0.12%
* Data source: directly measured on Listen Notes. リアルタイム
最新エピソード 🔗
"We can pass 10 executive orders. We can put $500 million for drug development. And if we don't have people who are willing to hold that space... we're not going to get anywhere." - Ismail Lourido Ali, MAP Co-CEOOn April 18th, just days before 420, Bicycle Day and MAPS’ own 40th anniversa…
以前のエピソード 🔗
Can we practice the art of surrender before the first dose?
Today on the show Robin Arnott and Dr. Sandeep Prakash explain how SoundSelf evolved from a VR curiosity into a clinically oriented tool that uses sound and light feedback to induce the unitary states therapists aim for in medicine session…
Imagine you’re in the middle of a psychedelic journey—things are getting intense, and you just need someone to talk to. That’s whereFireside Project comes in. As the world’s first psychedelic peer support line, Fireside is redefining how we care for each other in altered states, offering a space wh…
A month ago, I had the privilege of visiting Beond in Cancun, Mexico to experience an ibogaine treatment for cognitive enhancement. Today, I’m joined by Beond CEO Tom Feegel to discuss how this remarkable medicine can support a better brain.
In this episode, we explore Tom’s personal journey with …
Today, I’m joined by Juan Pablo Capello, co-founder and former CEO of New Life Health, a telehealth ketamine therapy service launched in 2021. Juan Pablo has raised concerns about low standards of care in telehealth ketamine, making this a timely conversation about the opportunities and challenges …
Today, we’re exploring a critical issue facing the field of psychedelic medicine: the recent FDA rejection of MAPS’ clinical trials to reschedule MDMA for therapeutic use. This setback affects many of us committed to healing and transforming society through psychedelics.
To help us understand the…
Today we’re doing something a little different. I’m re-releasing an episode from my personal podcast, Life is a Festival, because it remains one of my favorite interviews ever. This conversation, originally recorded a few years ago, is with Tricia Eastman and Joseph Barsuglia, two pioneers in the w…
After the shocking decision of an advisory committee recommendation that the FDA reject MDMA as a treatment for post-traumatic stress disorder, I wanted to speak to someone who understands the difference between clinical trials and private practice. Dr. Jennifer Tippett is a licensed clinical psych…
A year and a half ago, I went on an antidepressant medication, Wellbutrin, which is a dopamine and norepinephrine reuptake inhibitor. After 20 years of plant medicine, meditation, therapy, and other healing modalities, which I still use, I was still experiencing persistent challenges. With the supp…
Welcome back to the Psychedelic Therapy Podcast. I'm your host, Eamon Armstrong. Today on the show, we're welcoming back Tony Moss. Tony is an artist, producer, and member of the Bird Tribe Music Collective. He is also an ayahuasca facilitator with 30 years of experience and has just released a new…
免責: このページに埋め込まれているポッドキャストとアートワークは Eamon Armstrong からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。
ポッドキャスト検索エンジン
当社の Web サイトを使用して、人、場所、トピックごとに 3,830,836 ポッドキャストや 196,697,213 エピソードを検索できます。
知識への投資は最も大きな利益をもたらす。だから私はポッドキャストを聴く。
‐ Benjamin "Llamacorn" Franklin
ポッドキャストがクレームを受けています
This podcast page is claimed and managed by
@e8119
